TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 10 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,327,000 | +4.9% | 106,394 | +15.9% | 0.15% | +6.9% |
| Q2 2015 | $2,218,000 | -3.1% | 91,793 | +0.3% | 0.14% | +4.3% |
| Q1 2015 | $2,288,000 | +26.9% | 91,495 | +5.8% | 0.14% | +25.5% |
| Q4 2014 | $1,803,000 | -13.7% | 86,511 | -10.0% | 0.11% | -14.1% |
| Q3 2014 | $2,090,000 | +13.6% | 96,140 | +21.2% | 0.13% | +10.3% |
| Q2 2014 | $1,839,000 | +1.0% | 79,306 | +3.4% | 0.12% | -7.2% |
| Q1 2014 | $1,821,000 | +8.1% | 76,670 | +4.5% | 0.12% | +6.8% |
| Q4 2013 | $1,685,000 | -30.7% | 73,384 | -28.8% | 0.12% | -33.1% |
| Q3 2013 | $2,433,000 | +11.5% | 103,025 | +6.4% | 0.18% | +6.1% |
| Q2 2013 | $2,183,000 | – | 96,813 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |